Thursday, March 20, 2014

Chemotherapy proven to cause long, agonizing, suffering death

New evidence confirms what we've known here at Natural News for some time -- that chemotherapy is one of the worst forms of cancer treatment there is, primarily because of the horrific chemicals involved, but also because it is simply an agonizing way to kill.

According to a newly published study in the British Medical Journal, more than half of end-stage cancer patients are given chemotherapy during the final few months of their life, and those who received such treatment were much more likely to die uncomfortably: in a hospital intensive care unit hooked to a ventilator, rather than at home as they wanted.

In addition, the study found, patients were not as likely to have discussed their end-of-life wishes with their oncologist, compared to other final-stage cancer patients who chose to discontinue their chemotherapy treatments.

The researchers went on to report that physicians tend to have a difficult time beginning conversations with their patients over such care, especially those who are stricken with, and dying from, metastatic cancers.

'Doctors are human beings, too'

Dr. Alexi Wright, an assistant professor of medicine at Boston's Dana-Farber Cancer Institute and the study's lead author, told The Boston Globe, "There's a subtle dance that happens between oncologist and patient, where doctors don't want to broach the subject of dying, especially in younger patients, because it makes those patients think we're giving up on them."

Wright and her research team studied 386 terminally ill cancer patients, discovering that the 56 percent of them who had chemotherapy tended to be younger, more educated and more optimistic about their prognosis. All of the patients died within an average of four months after participating in the study.

Of the participants who took chemotherapy, only 65 percent died in their preferred place, compared to 80 percent of those who chose to end their treatments.

For the rest of the story:

No comments:

Post a Comment